06/07/2026
A recent prospective clinical study published in the prestigious Sexual Medicine journal by Oxford University Presshighlighted the clinical success of Modus ESWT technology in the treatment of vasculogenic erectile dysfunction (ED) and introduced an innovative clinical scoring system to the medical community.
The high treatment success rates enabled the researchers to further investigate the question, “Which patient profile benefits the most from this therapy?” Based on these findings, a new clinical scoring system was developed to help physicians identify the most suitable candidates, predict treatment outcomes more accurately, and design personalized treatment strategies.